UPCOMING ONLINE JOURNAL CLUB: Statin Use for Older Adults in Primary Care

Date: Monday 12 October 2026

Time: 6–7pm AEST

Where: Online via Zoom

Register to receive the Zoom link: https://bond.zoom.us/meeting/register/lkry8KiCRq6H9eUYPAL-dw

Statins are among the most commonly prescribed medicines in older adults, yet the evidence for starting them for primary prevention in this age group has been limited. Two recently published trials now speak directly to that decision, and to whether statins can be safely stopped in people already taking them.

This journal club will work through both trials and what they mean for everyday practice.

Discussion articles

Zoungas S, Wolfe R, Moran C, et al. Atorvastatin, cardiovascular events, and disability-free survival in older adults. The New England Journal of Medicine. 2026. doi:10.1056/NEJMoa2607314

Galli G, Rousset M, Coueron R, et al. Discontinuation of statins for primary prevention of atherosclerotic cardiovascular disease in adults aged 75 years or older (SAGA/SITE): a multicentre, open-label, pragmatic, non-inferiority randomised trial. The Lancet Healthy Longevity. 2026;7(7):100884. doi:10.1016/j.lanhl.2026.100884

The journal club will include

• A welcome and introductory case study from Professor Nick Zwar, local GP and Executive Dean, Faculty of Health Sciences and Medicine, Bond University.

• A critical appraisal of both trials by Associate Professor Loai Albarqouni.

• Expert commentary from guest speakers Professor Mark Nelson (Tasmanian School of Medicine, University of Tasmania), an author of the NEJM trial, and Professor Paul Glasziou (Emeritus Professor, Bond University), reflecting on the implications for primary care.

• Open discussion and audience questions.

The session is designed for GPs, nurses, allied health professionals and anyone working in primary care.